SAFE-BioPharma opens competition for 'Digi' digital-identity award
Nonprofit seeks to raise profile of the value of industry-wide identity-authentication standards
About 35 pharma manufacturers, distributors and organizations involved with healthcare delivery are now member of SAFE-BioPharma Assn., a Teaneck, NJ-based nonprofit set up to develop standards for digital-identity verification and trust. As more and more of industry activities move to cloud-based applications, the complexity of managing access, protecting against intrusions and ensuring data integrity multiplies; SAFE-BioPharma is meant to address these concerns. Its original focus among clinical investigators and researchers has now broadened to include aspects of pharmaceutical distribution and prescribing, including the DEA-managed controlled-substances ordering system (CSOS).
To highlight this growing need, SAFE-BioPharma has organized an awards competition, says Mollie Shields-Ueling, CEO of the association, open through January 15 for nominees. Categories include innovative implementations; regulatory advances; and innovative compliance initiatives. “Data exchange among pharma companies and the businesses and individuals they interact with remain a Tower of Babel, costing the industry time, money and effort,” she says.
More information is available at the SAFE-BioPharma website.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
